BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 29358469)

  • 1. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.
    Mantovani A; Byrne CD; Bonora E; Targher G
    Diabetes Care; 2018 Feb; 41(2):372-382. PubMed ID: 29358469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
    Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.
    Mantovani A; Petracca G; Beatrice G; Tilg H; Byrne CD; Targher G
    Gut; 2021 May; 70(5):962-969. PubMed ID: 32938692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis.
    Gao Y; Zhao T; Song S; Duo Y; Gao J; Yuan T; Zhao W
    Diabetes Res Clin Pract; 2023 Jun; 200():110699. PubMed ID: 37169306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Mantovani A; Nascimbeni F; Lonardo A; Zoppini G; Bonora E; Mantzoros CS; Targher G
    Thyroid; 2018 Oct; 28(10):1270-1284. PubMed ID: 30084737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis.
    Mantovani A; Petracca G; Beatrice G; Csermely A; Lonardo A; Schattenberg JM; Tilg H; Byrne CD; Targher G
    Gut; 2022 Jan; 71(1):156-162. PubMed ID: 33303564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
    Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
    Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.
    Mantovani A; Turino T; Altomari A; Lonardo A; Zoppini G; Valenti L; Tilg H; Byrne CD; Targher G
    Metabolism; 2019 Jul; 96():56-65. PubMed ID: 31047909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.
    Mantovani A; Petracca G; Beatrice G; Csermely A; Tilg H; Byrne CD; Targher G
    Gut; 2022 Apr; 71(4):778-788. PubMed ID: 33685968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.
    Targher G; Byrne CD; Lonardo A; Zoppini G; Barbui C
    J Hepatol; 2016 Sep; 65(3):589-600. PubMed ID: 27212244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis.
    Mantovani A; Gatti D; Zoppini G; Lippi G; Bonora E; Byrne CD; Nobili V; Targher G
    Hepatology; 2019 Sep; 70(3):812-823. PubMed ID: 30706504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density.
    Mantovani A; Dauriz M; Gatti D; Viapiana O; Zoppini G; Lippi G; Byrne CD; Bonnet F; Bonora E; Targher G
    Aliment Pharmacol Ther; 2019 Feb; 49(4):375-388. PubMed ID: 30600540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
    Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
    J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of non-alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta-analysis of observational studies.
    Song D; Li C; Wang Z; Zhao Y; Shen B; Zhao W
    J Diabetes Investig; 2021 Aug; 12(8):1471-1479. PubMed ID: 33372390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
    Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
    Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood.
    Bardugo A; Bendor CD; Zucker I; Lutski M; Cukierman-Yaffe T; Derazne E; Mosenzon O; Tzur D; Beer Z; Pinhas-Hamiel O; Ben-Ami M; Fishman B; Ben-Ami Shor D; Raz I; Afek A; Gerstein HC; Häring HU; Tirosh A; Levi Z; Twig G
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e34-e44. PubMed ID: 33075820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study.
    Bae JC; Han JM; Cho JH; Kwon H; Park SE; Park CY; Lee WY; Oh KW; Kwon S; Park SW; Rhee EJ
    Diabetes Res Clin Pract; 2018 Jan; 135():1-6. PubMed ID: 29111276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.